Lindus Health Names Heather Davis Vice President of U.S. Clinical Operations

Appointment supports expansion of company’s clinical trials footprint in North America

Lindus Health has appointed Heather Davis as Vice President of U.S. Clinical Operations. She will oversee operational teams supporting the company’s U.S.-based clinical trial portfolio.

The company, headquartered in Boston, has conducted more than 30 U.S. studies across a range of therapeutic areas. Recent examples include a Phase III study with Sooma for a major depressive disorder therapy and a 500-patient study with Cleo related to an ovarian cancer product submission.

Davis has more than three decades of experience in clinical research and previously served as Chief Operations Officer at Highline Sciences, where she led operational expansion prior to the firm’s acquisition by Tempus. She later became COO of Tempus Compass.

“I’m excited to build on that experience at Lindus Health,” Davis said. “There is now greater flexibility in how to use technology to expedite clinical research.”

Lindus Health said the appointment is part of its broader plans to scale staff and delivery capacity in North America.